Everyone knows that faster and cheaper genome sequencing is ushering in a new era of healthcare. What many people don’t fully realize, however, is how the confluence of “big biology” with “big data” is opening huge opportunities for innovative tech startups and established players alike—in areas from next-generation sequencing to data acquisition, storage, distribution, analysis, and more.

With its expertise in high-performance computing, predictive analytics, and software development, coupled with its leadership in genomics, brain science, biotechnology, and digital health, San Diego is uniquely poised to be a leader in this data-biology confluence.

Please join Xconomy San Diego for a half-day forum that will highlight the prospects—and challenges—facing technology innovators on both the big data and big biology sides of this equation.

Confirmed Speakers:
Ilkay Altintas, Chief Data Science Officer, San Diego Supercomputer Center
John Blume, CSO, Applied Proteomics
Francis deSouza, President and successor CEO, Illumina
Doug Eveland, CIO, CureMetrix
Lucian Iancovici, Senior Investment Manager, Qualcomm Life Fund
Kim Kamdar, Partner, Domain Associates
Stephen Kingsmore, President and CEO, Rady Pediatric Genomics and Systems Medicine Institute
Rob Knight, Professor of Pediatrics and Computer Science & Engineering, UC San Diego
Lance Myers, CTO, Sentrian
Franz Och, Chief Data Scientist, Human Longevity
Nicholas Schork, Professor and Director of Human Biology, J. Craig Venter Institute
Aditya Rajagopal, CTO, ChromaCode
Naveen Rao, Founder and CEO, Nervana Systems
Pieter van Rooyen, President and CEO, Edico Genome

Twitter:
@Xconomy
#xconbig

Schedule:
Registration: 1:00 – 2:00 pm
Program: 2:00 – 5:45 pm
Networking reception: 5:45 – 6:45 pm
Full agenda

Registration Information:
Tickets are transferable but not refundable.
To inquire about press registration, e-mail events@xconomy.com.

EVENT HOST AND PLATINUM SPONSOR

GOLD SPONSORS

SILVER SPONSORS

NATIONAL PARTNER
Alexandria Real Estate Equities

UNDERWRITERS
BIOCOM • BioCrossroads • EY • Jacobs Global Buildings
Johnson & Johnson Innovation • LaVoieHealthScience
Sarepta Therapeutics • TEVA Pharmaceuticals • Texas Medical Center

VENTURE CAPITAL MEMBERS
Atlas Venture • Avalon Ventures • LaunchCapital
Polaris Partners • Santé Ventures • SR One
TVC Capital • Third Rock Ventures

LIFE SCIENCE MEMBERS
Acorda Therapeutics • Alnylam Pharmaceuticals
Arrowhead Research • Bayer • CRG • Genocea Biosciences
Health Advances • LabConnect